Search

Involvement of the ADAM 12 in Thrombin-Induced Rats VSMCs Proliferation

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 3382-3386
Author(s): K. Smiljanic, B. Dobutovic, M. Obradovic, D. Nikolic, P. Marche, E. R. Isenovic

An Overview of Thrombin Inhibitors in the Perspective of StructureactivityRelationships

Journal: Current Medicinal Chemistry
Volume: 30 Issue: 25 Year: 2023 Page: 2864-2930
Author(s):

The Research Progress of Direct Thrombin Inhibitors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 20 Issue: 16 Year: 2020 Page: 1574-1585
Author(s): Zhi-Gang Sun,Yang-Liu,Jin-Mai Zhang,Shi-Chang Cui,Zhi-Gang Zhang,Hai-Liang Zhu

Thrombin-Activatable Fibrinolysis Inhibitor

Journal: Current Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2004 Page: 2335-2348
Author(s): Pauline F. Marx

Insulin, Thrombin, ERK1/2 Kinase and Vascular Smooth Muscle Cells Proliferation

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 3895-3902
Author(s): Esma R. Isenovic, Sanja Soskic, Andreja Trpkovic, Branislava Dobutovic, Milan Popovic, Zoran Gluvic, Biljana Putnikovic, Pierre Marche

Recent Developments in Thrombin-Activatable Fibrinolysis Inhibitor Research

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2009 Page: 1165-1173
Author(s): Pauline F. Marx, Chantal J.N. Verkleij, Mercedes Valls Seron, Joost C.M. Meijers

Characterization of Major Zinc Containing Myonecrotic and Procoagulant Metalloprotease ‘Malabarin’ from Non Lethal Trimeresurus malabaricus Snake Venom with Thrombin Like Activity: Its Neutralization by Chelating Agents

Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 2 Year: 2011 Page: 2578-2588
Author(s): C. D. Raghavendra Gowda, H. V. Shivaprasad, R. Venkatesh Kumar, R. Rajesh, Y. K. Saikumari, B. M. Frey, F. J. Frey, B. K. Sharath, B. S. Vishwanath

New Oral Anticoagulants for Venous Thromboembolism: Focus on Factor Xa and Thrombin Inhibitors

Journal: Current Drug Discovery Technologies
Volume: 9 Issue: 2 Year: 2012 Page: 119-128
Author(s): Cecilia Becattini,Alessandra Lignani,Giancarlo Agnelli

Thrombin Activable Fibrinolysis Inhibitor (TAFI): Molecular Genetics of an Emerging Potential Risk Factor for Thrombotic Disorders

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 1 Issue: 2 Year: 2001 Page: 59-74
Author(s): M. B. Boffa, M. E. Nesheim, M. L. Koschinsky

Journal: Protein & Peptide Letters
Volume: 15 Issue: 8 Year: 2008 Page: 799-805
Author(s): T. Hianik, A. Porfireva, I. Grman, G. Evtugyn